Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

597 ARTÍCULOS , VIENDO DEL 421 AL 435

Nutrition: Review on the Possible Treatment for Alzheimer's Disease

Botchway BOA, Moore MK, Akinleye FO, Iyer IC, Fang M.

J Alzheimers Dis. 2018;61(3):867-883. doi: 10.3233/JAD-170874.

Emergency Department Use by Community-Dwelling Individuals With Dementia in the United States: An Integrative Review

Hunt LJ, Coombs LA, Stephens CE.

J Gerontol Nurs. 2018 Mar 1;44(3):23-30. doi: 10.3928/00989134-20171206-01. Epub 2018 Jan 23.

Can Exercise Improve Cognitive Symptoms of Alzheimer's Disease?

Panza GA, Taylor BA, MacDonald HV, Johnson BT, Zaleski AL, Livingston J, Thompson PD, Pescatello LS.

J Am Geriatr Soc. 2018 Mar;66(3):487-495. doi: 10.1111/jgs.15241. Epub 2018 Jan 24.

Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target

Caraci F, Spampinato SF, Morgese MG, Tascedda F, Salluzzo MG, Giambirtone MC, Caruso G, Munafò A, Torrisi SA, Leggio GM, Trabace L, Nicoletti F, Drago F, Sortino MA, Copani A.

Pharmacol Res. 2018 Apr;130:374-384. doi: 10.1016/j.phrs.2018.02.007. Epub 2018 Feb 10.

Memantine in Japanese patients with moderate to severe Alzheimer's disease: meta-analysis of multiple-index responder analyses

Okuizumi K, Kamata T, Matsui D, Saito K, Matsumoto T, Fukuchi Y.

Expert Opin Pharmacother. 2018 Apr;19(5):425-430. doi: 10.1080/14656566.2018.1442440. Epub 2018 Mar 6.

Memorcise and Alzheimer's disease

Loprinzi PD, Frith E, Ponce P.

Phys Sportsmed. 2018 May;46(2):145-154. doi: 10.1080/00913847.2018.1445932. Epub 2018 Mar 9.

A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer's Disease

Dubé S, Megerian JT, Malamut R.

J Prev Alzheimers Dis. 2018;5(2):120-133. doi: 10.14283/jpad.2018.17.

Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease

Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L.

J Prev Alzheimers Dis. 2018;5(2):149-154. doi: 10.14283/jpad.2018.18.

New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease

Zhong KL, Chen F, Hong H, Ke X, Lv YG, Tang SS, Zhu YB.

Metab Brain Dis. 2018 Aug;33(4):1009-1018. doi: 10.1007/s11011-018-0227-1. Epub 2018 Apr 6.

Exercise Intervention Associated with Cognitive Improvement in Alzheimer's Disease

Cui MY, Lin Y, Sheng JY, Zhang X, Cui RJ.

Neural Plast. 2018 Mar 11;2018:9234105. doi: 10.1155/2018/9234105. eCollection 2018.

The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease

Creese B, Da Silva MV, Johar I, Ballard C.

Expert Rev Neurother. 2018 Jun;18(6):461-467. doi: 10.1080/14737175.2018.1476140. Epub 2018 May 21.

Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: A PRISMA-compliant network meta-analysis

Liang JH, Xu Y, Lin L, Jia RX, Zhang HB, Hang L.

Medicine (Baltimore). 2018 May;97(20):e10744. doi: 10.1097/MD.0000000000010744.

Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease

Hussain A, Tabrez ES, Mavrych V, Bolgova O, Peela JR.

Crit Rev Eukaryot Gene Expr. 2018;28(1):67-72. doi: 10.1615/CritRevEukaryotGeneExpr.2018021391.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias